Search clinical trials for: dyslipidemia

Total 2973 results

Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)

Hypercholesterolaemia

Netherlands, United States, Canada, Russian Federation, South Africa
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)

Hypercholesterolemia

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan

Hypercholesterolemia

Japan
Daiichi Sankyo, Inc.

Completed

Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin

Type 2 Diabetes | Hyperlipidemia

United States
Xention Ltd

Completed

ADME Study in Healthy Male Subjects With TA-8995

Dyslipidemia

United Kingdom
University of Missouri-Columbia
National Library of Medicine (NLM)

Completed

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

Depression | HIV Infections | Hypertension | Obesity | Diabetes Mellitus | Back Pain | Urinary Incontinence | Irritable Bowel Syndrome | Insomnia | Asthma | Anxiety | Sinusitis | Shoulder Pain | Allergic Rhinitis | Urinary Tract Infection | Vaginitis | Bursitis | Hyperlipidemia | Esophageal Reflux | Benign Prostatic Hypertrophy | Osteoporosis... and other conditions

United States
University of Missouri-Columbia
National Library of Medicine (NLM)

Completed

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Depression | Coronary Artery Disease | HIV Infections | Smoking Cessation | Hypertension | Obesity | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Hypothyroidism | Back Pain | Urinary Incontinence | Irritable Bowel Syndrome | Diarrhea | Migraine Disorders | Cough | Sleep Initiation and Maintenance... and other conditions
Assistance Publique - Hôpitaux de Paris

Completed

Intestines and Liver Contribution to Fasting Postprandial Hypertriglyceridemia (TRIGPP)

Metabolic Syndrome | Hypertriglyceridemia

France
Tate & Lyle
BioFortis

Completed

A Study to Evaluate the Effects of Dietary Fiber on Blood Lipids in Men and Women

Hypercholesterolemia

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy Volunteers

Hypercholesterolemia

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects

Hypercholesterolemia

France
Ohio State University
National Institute of General Medical Sciences (NIGMS)

Withdrawn

Genetic Influence on Statin Pharmacodynamics

Dyslipidemia | Hypercholesterolemia | Hyperlipidemia

United States
Novartis Pharmaceuticals

Withdrawn

Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients

Familial Hypercholesterolemia
Yonsei University

Completed

Nattokinase Supplementation and Hemostatic Factors

Hypercholesterolemia

Korea, Republic of
Ondokuz Mayıs University

Completed

PERIODONTAL DISEASE AND HYPERLIPIDEMIA

Hyperlipidemia, Periodontitis, Gingivitis
Takeda

Completed

Efficacy of TAK-085 in Participants With Hypertriglyceridemia

Hypertriglyceridemia
Takeda

Completed

Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia

Hypertriglyceridemia
Hospital de Clinicas de Porto Alegre

Completed

Effects of Two Aquatic Training Models in Physiological Parameters of Elderly Dyslipidemic Women.

Dyslipidemias
University of Chile
Pontificia Universidad Catolica de Chile

Completed

Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols (ACTICOL)

Dyslipidemias | Hypercholesterolemia

Chile
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Hypercholesterolemia | Coronary Heart Disease

United States
University of Texas at Austin
Dairy Research Institute

Completed

Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal

Oral Glucose Tolerance Test | High Fat Tolerance Test

United States
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis

Hypercholesterolemia | Coronary Heart Disease

South Africa, Germany, United States, United Kingdom, Canada, Czech Republic
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia

Metabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Hyperlipoproteinemias | Lipid Metabolism, Inborn Errors | Hyperlipoproteinemia Type II | Metabolic... and other conditions

United States
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects (ASSIST)

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Metabolic Disorder

Netherlands
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease (RADICHOL II)

Coronary Artery Disease | Heterozygous Familial Hypercholesterolemia

United States, Canada
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia

Metabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Hyperlipoproteinemias | Lipid Metabolism, Inborn Errors | Hyperlipoproteinemia Type II | Metabolic... and other conditions

United States, Canada, Brazil, Taiwan, Singapore, South Africa, United Kingdom
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia (RADICHOL 1)

Metabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Hyperlipoproteinemias | Lipid Metabolism, Inborn Errors | Hyperlipoproteinemia Type II | Metabolic... and other conditions

United States, Taiwan, Brazil, Canada, South Africa, United Kingdom, Singapore
Cairo University

Completed

Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis

Fenofibrate/Simvastatin Comparison
University of Utah
Abbott

Terminated

Study of Trilipix Effects on Lipids and Arteries

Dyslipidemia

United States
Essentialis, Inc.

Withdrawn

Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline

Hypertriglyceridemia
Essentialis, Inc.

Withdrawn

Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

Hypertriglyceridemia
Instituto Aragones de Ciencias de la Salud

Completed

Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia

Hypertriglyceridemia | Hyperferritinemia

Spain
AstraZeneca

Completed

Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) (ECLIPSEIII)

Hypertriglyceridemia

United States
Isfahan University of Medical Sciences

Unknown

Developing and Implementing Familial Hypercholesterolemia Registry

Familial Hypercholesterolemia

Iran, Islamic Republic of
Korea University Anam Hospital
Samjin Pharmaceutical Co., Ltd.

Unknown

Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI (ROSUVA-30)

Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease

Korea, Republic of
Arisaph Pharmaceuticals Inc

Unknown

Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia (REASCEND)

Hyperlipidemia

United States
Arisaph Pharmaceuticals Inc
Baim Institute for Clinical Research

Completed

Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia

Hypertriglyceridemia

United States
AstraZeneca

Completed

Epanova® for Lowering Very High Triglycerides (EVOLVE)

Severe Hypertriglyceridemia

United States, Hungary, India, Russian Federation, Denmark, Ukraine, Netherlands
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)

Hypercholesterolemia

United States, Canada, Denmark, France, Hungary, Israel, Korea, Republic of, Russian Federation, South Africa, Ukraine
Koval' O., MD

Unknown

Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome

Diabetes Mellitus, Type 2 | Acute Coronary Syndrome | Hypertriglyceridemia

Ukraine
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

Hypercholesterolemia, Familial

United States, Netherlands
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

Hypercholesterolemia, Familial

United States, Netherlands
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-cholesterol Levels

Hypercholesterolemia

Germany
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Dose-escalating Safety Study in Subjects on Stable Statin Therapy

Hypercholesterolemia

Netherlands, United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Strong Heart Study

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypertension | Obesity | Diabetes Mellitus | Atherosclerosis | Asthma | Carotid Artery Diseases | Hypercholesterolemia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Mechanisms of Low Levels of Apolipoprotein B

Heart Diseases | Cardiovascular Diseases | Hypobetalipoproteinemia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Heart Failure | Coronary Disease | Hypertension | Diabetes Mellitus | Hypercholesterolemia
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis (ENTHRALL)

Dyslipidemias

United States
Catabasis Pharmaceuticals

Completed

Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia (PATHWAYS I)

Dyslipidemia | Hypercholesterolemia | Hypertriglyceridemia

United States, Canada
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of

Search clinical trials for: dyslipidemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations